DOTmed January 10, 2025
Stryker has announced plans to acquire Inari Medical Inc. for $80 per share in cash, valuing the transaction at approximately $4.9 billion.
The acquisition will position the Portage, Michigan-based company in the growing peripheral vascular market, with a focus on venous thromboembolism (VTE) solutions. Inari, headquartered in Irvine, California, specializes in mechanical thrombectomy devices for conditions like deep vein thrombosis and pulmonary embolism.
The deal, unanimously approved by both companies’ boards, is expected to close by the end of the first quarter of 2025, pending regulatory approvals and other conditions.
“Expanding our portfolio into the peripheral vascular space allows us to provide lifesaving solutions to patients suffering from...
Today's Sponsors
Today's Sponsor